Benzinga's Volume Movers

Puma Biotechnology

shares moved up 269.83% to $218.31. The volume of Puma Biotechnology shares traded was 2957% higher than normal. Puma Biotechnology released positive top line results from its Phase 3 PB272 trial in initial treatment for breast cancer. Inovio Pharmaceuticals

shares rose 15.57% to $12.88. The volume of Inovio Pharmaceuticals shares traded was 977% higher than normal. Inovio Pharmaceuticals' HPV immunotherapy has achieved primary efficacy endpoint in randomized phase II cervical dysplasia trial. Talisman Energy

surged 12.89% to $11.12. The volume of Talisman Energy shares traded 729% higher than normal. Talisman Energy is expected to release its Q2 results on July 29, 2014. Intuitive Surgical

shares climbed 13.26% to $444.15. The volume of Intuitive Surgical shares traded was 651% higher than normal. Intuitive Surgical reported better-than-expected Q2 earnings. Analysts at Raymond James upgraded Intuitive Surgical from Market Perform to Outperform.